array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(27) "Tekla World Healthcare Fund"
["slug"]=>
string(36) "b56a5-us-tekla-world-healthcare-fund"
["logo"]=>
NULL
["description"]=>
string(834) "Tekla World Healthcare Fund is a diversified closed-end fund that primarily invests in the healthcare industry. Its objective is to seek current income and long-term capital appreciation through investments in companies engaged in the healthcare industry, including equity securities and debt securities. The fund is traded on the New York Stock Exchange under the ticker THW. As of September 6, 2023, the fund's net asset value (NAV) was $12.25 and the market price was $13.08, representing a premium/discount of 6.78%. The fund has a current distribution rate of 10.52% and paid a monthly dividend per share of $0.1167 on August 31, 2023. Please note that the distribution classifications are preliminary and may be re-classified at year-end. More information about the fund can be found on the Tekla Capital Management LLC website."
["address_street"]=>
string(20) "100 Federal St FL 19"
["address_place"]=>
string(6) "Boston"
["address_region"]=>
string(13) "Massachusetts"
["founding_date"]=>
string(10) "2015-01-26"
["website_domain"]=>
string(12) "teklacap.com"
["website_url"]=>
string(57) "https://www.teklacap.com/funds/thw/info/fund-information/"
["industry_codes"]=>
array(1) {
[0]=>
string(101) "Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices"
}
["employee_count"]=>
int(3)
["article_count"]=>
int(154)
}
["articles"]=>
array(4) {
[0]=>
array(7) {
["title_en"]=>
string(72) "Tekla Capital Management LLC Announces Closing of Transaction With abrdn"
["snippet_en"]=>
string(300) "BOSTON–(BUSINESS WIRE)–HQH, HQL, THQ, THW Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic"
["url"]=>
string(101) "https://www.fintechnews.org/tekla-capital-management-llc-announces-closing-of-transaction-with-abrdn/"
["image_url"]=>
NULL
["source"]=>
string(15) "fintechnews.org"
["publication_date"]=>
string(10) "2023-10-29"
["categories"]=>
array(5) {
[0]=>
string(25) "Business Model Resilience"
[1]=>
string(10) "Divestment"
[2]=>
string(20) "Business Development"
[3]=>
string(22) "Business Restructuring"
[4]=>
string(11) "Acquisition"
}
}
[1]=>
array(7) {
["title_en"]=>
string(72) "Tekla Capital Management LLC Announces Closing of Transaction With abrdn"
["snippet_en"]=>
string(297) "Tekla Capital Management LLC announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic closed-end funds, totaling$ 2.8 bn in assets under"
["url"]=>
string(120) "https://www.nasdaq.com/press-release/tekla-capital-management-llc-announces-closing-of-transaction-with-abrdn-2023-10-27"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2023-06-30"
["categories"]=>
array(5) {
[0]=>
string(25) "Business Model Resilience"
[1]=>
string(10) "Divestment"
[2]=>
string(20) "Business Development"
[3]=>
string(22) "Business Restructuring"
[4]=>
string(11) "Acquisition"
}
}
[2]=>
array(7) {
["title_en"]=>
string(70) "Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc."
["snippet_en"]=>
string(190) "Tekla Capital Management LLC announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds."
["url"]=>
string(118) "https://www.nasdaq.com/press-release/tekla-funds-approve-new-investment-advisory-agreements-with-abrdn-inc.-2023-10-27"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2023-06-30"
["categories"]=>
array(5) {
[0]=>
string(13) "Collaboration"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(15) "Deals & Tenders"
[3]=>
string(19) "Investment Requests"
[4]=>
string(18) "General Investment"
}
}
[3]=>
array(7) {
["title_en"]=>
string(78) "abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM"
["snippet_en"]=>
string(269) "abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in Boston, Massachusetts."
["url"]=>
string(84) "https://finance.yahoo.com/news/abrdn-acquire-us-specialist-healthcare-221500989.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/965c9901-84c5-4864-8fbd-8c2564370b75"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-06-20"
["categories"]=>
array(3) {
[0]=>
string(25) "Business Model Resilience"
[1]=>
string(11) "Acquisition"
[2]=>
string(18) "General Investment"
}
}
}
["category_annotations"]=>
array(25) {
[0]=>
array(2) {
["name"]=>
string(10) "Tax Havens"
["count"]=>
int(18)
}
[1]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(14)
}
[2]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(9)
}
[3]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(5)
}
[4]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(4)
}
[5]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(3)
}
[6]=>
array(2) {
["name"]=>
string(18) "Business Structure"
["count"]=>
int(3)
}
[7]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(3)
}
[8]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(3)
}
[9]=>
array(2) {
["name"]=>
string(22) "Business Restructuring"
["count"]=>
int(2)
}
[10]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(2)
}
[11]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(2)
}
[12]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(2)
}
[13]=>
array(2) {
["name"]=>
string(19) "Investment Requests"
["count"]=>
int(2)
}
[14]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(1)
}
[15]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(1)
}
[16]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(1)
}
[17]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(1)
}
[18]=>
array(2) {
["name"]=>
string(16) "Share Repurchase"
["count"]=>
int(1)
}
[19]=>
array(2) {
["name"]=>
string(21) "Cultural developments"
["count"]=>
int(1)
}
[20]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(1)
}
[21]=>
array(2) {
["name"]=>
string(5) "Debts"
["count"]=>
int(1)
}
[22]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(1)
}
[23]=>
array(2) {
["name"]=>
string(17) "Commodity Pricing"
["count"]=>
int(1)
}
[24]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(1)
}
}
}
b56a5-us-tekla-world-healthcare-fund
Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices
Description
Tekla World Healthcare Fund is a diversified closed-end fund that primarily invests in the healthcare industry. Its objective is to seek current income and long-term capital appreciation through investments in companies engaged in the healthcare industry, including equity securities and debt securities. The fund is traded on the New York Stock Exchange under the ticker THW. As of September 6, 2023, the fund's net asset value (NAV) was $12.25 and the market price was $13.08, representing a premium/discount of 6.78%. The fund has a current distribution rate of 10.52% and paid a monthly dividend per share of $0.1167 on August 31, 2023. Please note that the distribution classifications are preliminary and may be re-classified at year-end. More information about the fund can be found on the Tekla Capital Management LLC website.
BOSTON–(BUSINESS WIRE)–HQH, HQL, THQ, THW Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic
Tekla Capital Management LLC announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic closed-end funds, totaling$ 2.8 bn in assets under
Tekla Capital Management LLC announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds.
abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in Boston, Massachusetts.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.